These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11672929)

  • 81. [The protective activity of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus in rodent infection via the respiratory tract].
    Filatenkov AG; Khaltaeva GG; Khlebnikova NN; Gorban' SG; Shkurnikova NN; Khamitova MF
    Vopr Virusol; 1991; 36(3):229-31. PubMed ID: 1891877
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study.
    Baker EF; Sasso DR; Maness K; Prichard WD; Parker RL
    Am J Vet Res; 1978 Oct; 39(10):1627-31. PubMed ID: 717877
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.
    Johnston RE; Johnson PR; Connell MJ; Montefiori DC; West A; Collier ML; Cecil C; Swanstrom R; Frelinger JA; Davis NL
    Vaccine; 2005 Oct; 23(42):4969-79. PubMed ID: 16005121
    [TBL] [Abstract][Full Text] [Related]  

  • 85. CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product.
    Perkins SD; Williams AJ; O'Brien LM; Laws TR; Phillpotts RJ
    Viral Immunol; 2008 Dec; 21(4):451-7. PubMed ID: 19115934
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immunity to aerosol challenge in guinea pigs immunized with gamma-irradiated Venezuelan equine encephalitis vaccines.
    Reitman M; Tonik EJ
    Appl Microbiol; 1971 Apr; 21(4):688-92. PubMed ID: 5575570
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Host immune responses after administration of inactivated Venezuelan equine encephalomyelitis virus vaccines--III. Kinetics for neutralizing antibody immunoglobulin class responses in donors and adoptively-immunized recipients.
    Rabinowitz SG; Huprikar J; Whitacre C
    Comp Immunol Microbiol Infect Dis; 1979; 1(4):295-303. PubMed ID: 318539
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Second generation inactivated eastern equine encephalitis virus vaccine candidates protect mice against a lethal aerosol challenge.
    Honnold SP; Bakken RR; Fisher D; Lind CM; Cohen JW; Eccleston LT; Spurgers KB; Maheshwari RK; Glass PJ
    PLoS One; 2014; 9(8):e104708. PubMed ID: 25116127
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Vaccines for Venezuelan equine encephalitis.
    Paessler S; Weaver SC
    Vaccine; 2009 Nov; 27 Suppl 4():D80-5. PubMed ID: 19837294
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): comparison of naïve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells.
    Erwin-Cohen R; Porter A; Pittman P; Rossi C; Dasilva L
    Hum Vaccin Immunother; 2012 Aug; 8(8):1053-65. PubMed ID: 22617845
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Gamma-irradiated Venezuelan equine encephalitis vaccines.
    Reitman M; Tribble HR; Green L
    Appl Microbiol; 1970 May; 19(5):763-7. PubMed ID: 5463575
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors.
    Hodgson LA; Ludwig GV; Smith JF
    Vaccine; 1999 Mar; 17(9-10):1151-60. PubMed ID: 10195627
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Current strategic thinking for the development of a trivalent alphavirus vaccine for human use.
    Wolfe DN; Heppner DG; Gardner SN; Jaing C; Dupuy LC; Schmaljohn CS; Carlton K
    Am J Trop Med Hyg; 2014 Sep; 91(3):442-50. PubMed ID: 24842880
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [A method of fluorescent immunoenzyme analysis in the complex evaluation of viral and rickettsial vaccines].
    Mikhaĭlov VV; Pshenichnov VA; Kutuzov VA; Krasnianskiĭ VP; Lebedinskaia EV; Kruglova SE; Kirillov AP; Pashanina TP; Chernikova NK
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):76-81. PubMed ID: 7514329
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus.
    Williams AJ; O'Brien LM; Phillpotts RJ; Perkins SD
    Virol J; 2009 Jul; 6():118. PubMed ID: 19646224
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines.
    Reynolds JA; Harrington DG; Crabbs CL; Peters CJ; Di Luzio NR
    Infect Immun; 1980 Jun; 28(3):937-43. PubMed ID: 6772571
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inactivated Venezuelan equine encephalomyelitis vaccine prepared from attenuated (TC-83 strain) virus.
    Cole FE; May SW; Eddy GA
    Appl Microbiol; 1974 Jan; 27(1):150-3. PubMed ID: 4809906
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Resistance to arbovirus challenge in mice immediately after vaccination.
    Casals J; Buckley SM; Barry DW
    Appl Microbiol; 1973 May; 25(5):755-62. PubMed ID: 4577178
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Homegeneity of Venezuelan encephalitis virion populations of hamster-virulent and benign strains, including the attenuated TC83 vaccine.
    Jahrling PB; Scherer WF
    Infect Immun; 1973 Jun; 7(6):905-10. PubMed ID: 4716548
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant.
    Houston WE; Crabbs CL; Stephen EL; Levy HB
    Infect Immun; 1976 Jul; 14(1):318-9. PubMed ID: 820645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.